• 1
    Corrall CJ, Merz WG, Rekedal K, Hughes WT. Aspergillus osteomyelitis in an immunocompetent adolescent: a case report and review of the literature. Pediatrics 1982; 70: 45561.
  • 2
    Yu J, Cleveland TE, Niermann WC, Bennett JW. Aspergillus flavus genomics: gateway to human and animal health, food safety and crop resistance to diseases. Rev Iberoam Micol 2005; 22: 194202.
  • 3
    Rajendran C, Basu TK, Baby A, Kumari S, Verghese T. Incidence and significance of opportunistic fungi in leukemia patients in India. Mycopathologia 1992; 119: 8387.
  • 4
    Chakrabarti A, Gupta V, Biswas G, Kumar B, Sakhuja VK. Primary cutaneous aspergillosis: our experience in 10 years. J Infect 1998; 37: 2427.
  • 5
    Chakrabarti A, Sharma SC. Paranasal sinus mycoses. Indian J Chest Dis Allied Sci 2000; 42: 293304.
  • 6
    Chakrabarti A, Sharma SC, Chandler J. Epidemiology and pathogenesis of paranasal sinus mycoses. Otolaryngol Head Neck Surg 1992; 1: 74550.
  • 7
    Garg P, Mahesh S, Bansal AK, Gopinathan U, Rao GN. Fungal infection of sutureless self-sealing incision for cataract surgery. Ophthalmology 2003; 110: 21737.
  • 8
    Kaushik S, Ram J, Brar GS, Jain AK, Chakraborti A, Gupta A. Intracameral amphotericin B: initial experience in severe keratomycosis. Cornea 2001; 20: 7159.
  • 9
    Sridhar MS, Garg P, Bansal AK, Gopinathan U. Aspergillus flavus keratitis after laser in situ keratomileusis. Am J Ophthalmol 2000; 129: 8024.
  • 10
    Sridhar MS, Gopinathan U, Rao GN. Fungal keratitis associated with vernal keratoconjunctivitis. Cornea 2003; 22: 8081.
  • 11
    Steinbach WJ. Pediatric aspergillosis. Diagnosis and treatment differences in children. Pediatr Infect Dis J 2005; 24: 35864.
  • 12
    Hetherington SV, Henwick S, Parham DM, Patrick CC. Monoclonal antibodies against a 97-kilodalton antigen from Aspergillus flavus. Clin Diagn Lab Immunol 1994; 1: 6367.
  • 13
    Sutton DA, Fothergill AW, Rinaldi MG (eds). Guide to Clinically Significant Fungi, 1st edn. Baltimore, MD: Williams & Wilkins, 1998.
  • 14
    Sommer NF, Buchanan JR, Fortlage RJ. Aflatoxin and sterigmatocystin contamination of pistachio nuts in orchards. Appl Environ Microbiol 1976; 32: 6467.
  • 15
    Desai MR, Ghosh S. Occupational exposure to airborne fungi among rice mill workers with special reference to aflatoxin producing A. flavus strains. Ann Agric Environ Med 2003; 10: 15962.
  • 16
    Batista LR, Chalfoun SM, Prado G, Schwan RF, Wheals AE. Toxigenic fungi associated with processed (green) coffee beans (Coffea arabica L.). Int J Food Microbiol 2003; 85: 293300.
  • 17
    Desai MR, Ghosh SK. Aflatoxin related occupational exposure to maize processing workers. Cell Mol Biol (Noisy-le-grand) 2003; 49: 52935.
  • 18
    Mphande FA, Siame BA, Taylor JE. Fungi, aflatoxins, and cyclopiazonic acid associated with peanut retailing in Botswana. J Food Prot 2004; 67: 96102.
  • 19
    Takahashi H, Kamimura H, Ichinoe M. Distribution of aflatoxin-producing Aspergillus flavus and Aspergillus parasiticus in sugarcane fields in the southernmost islands of Japan. J Food Prot 2004; 67: 9095.
  • 20
    Adhikari A, Sen MM, Gupta-Bhattacharya S, Chanda S. Volumetric assessment of airborne fungi in two sections of a rural indoor dairy cattle shed. Environ Int 2004; 29: 10718.
  • 21
    Valenton M. Wound infection after cataract surgery. Jpn J Ophthalmol 1996; 40: 44755.
  • 22
    Heinemann S, Symoens F, Gordts B, Jannes H, Nolard N. Environmental investigations and molecular typing of Aspergillus flavus during an outbreak of postoperative infections. J Hosp Infect 2004; 57: 14955.
  • 23
    Llewellyn GC, O’Rear CE. Examination of fungal growth and aflatoxin production on marihuana. Mycopathologia 1977; 62: 10912.
  • 24
    Verweij PE, Kerremans JJ, Voss A, Meis JF. Fungal contamination of tobacco and marijuana. JAMA 2000; 284: 2875.
  • 25
    Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1996; 7: 5569.
  • 26
    Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003; 67: 40028.
  • 27
    Yang YL. Virulence factors of Candida albicans. J Microbiol Immunol Infect 2003; 36: 2238.
  • 28
    Stehr F, Felk A, Gacser A et al. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Res 2004; 4: 4018.
  • 29
    Schofield DA, Westwater C, Warner T, Balish E. Differential Candida albicans lipase gene expression during alimentary tract colonization and infection. FEMS Microbiol Lett 2005; 244: 35965.
  • 30
    Zhu WS, Wojdyla K, Donlon K, Thomas PA, Eberle HI. Extracellular proteases of Aspergillus flavus. Fungal keratitis, proteases, and pathogenesis. Diagn Microbiol Infect Dis 1990; 13: 4917.
  • 31
    Okumura Y, Ogawa K, Nikai T. Elastase and elastase inhibitor from Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger. J Med Microbiol 2004; 5: 3514.
  • 32
    Chou H, Lin WL, Tam MF, Wang SR, Han SH, Shen HD. Alkaline serine proteinase is a major allergen of Aspergillus flavus, a prevalent airborne Aspergillus species in the Taipei area. Int Arch Allergy Immunol 1999; 119: 28290.
  • 33
    Rhodes JC, Bode RB, McCuan-Kirsch CM. Elastase production in clinical isolates of Aspergillus. Dign Microbiol Infect Dis 1988; 10: 16570.
  • 34
    Ramesh MV, Sirakova T, Kolattukudy PE. Isolation, characterization, and cloning of cDNA and the gene for an elastinolytic serine proteinase from Aspergillus flavus. Infect Immun 1994; 62: 7985.
  • 35
    Yu CJ, Chiou SH, Lai WY, Chiang BL, Chow LP. Characterization of a novel allergen, a major IgE-binding protein from Aspergillus flavus, as an alkaline serine protease. Biochem Biophys Res Commun 1999; 261: 66975.
  • 36
    Ramesh MV, Kolattukudy PE. Disruption of the serine proteinase gene (sep) in Aspergillus flavus leads to a compensatory increase in the expression of a metalloproteinase gene (mep20). J Bacteriol 1996; 178: 3899907.
  • 37
    Monod M, Capoccia S, Lechenne B, Zaugg C, Holdom M, Jousson O. Secreted proteases from pathogenic fungi. Int J Med Microbiol 2002; 292: 40519.
  • 38
    Pavlukova EB, Belozersky MA, Dunaevsky YE. Extracellular proteolytic enzymes of filamentous fungi. Biochemistry (Mosc) 1998; 63: 899928.
  • 39
    Zhu LY, Nguyen CH, Sato T, Takeuchi M. Analysis of secreted proteins during conidial germination of Aspergillus oryzae RIB40. Biosci Biotechnol Biochem 2004; 68: 260712.
  • 40
    Van Kuyk PA, Cheetham BF, Katz ME. Analysis of two Aspergillus nidulans genes encoding extracellular proteases. Fungal Genet Biol 2000; 29: 20110.
  • 41
    Ten Have A, Dekkers E, Kay J, Phylip LH, Van Kan JA. An aspartic proteinase gene family in the filamentous fungus Botrytis cinerea contains members with novel features. Microbiology 2004; 7: 247589.
  • 42
    Gifford AH, Klippenstein JR, Moore MM. Serum stimulates growth of and proteinase secretion by Aspergillus fumigatus. Infect Immun 2002; 70: 1926.
  • 43
    Lee JD, Kolattukudy PE. Molecular cloning of the cDNA and gene for an elastinolytic aspartic proteinase from Aspergillus fumigatus and evidence of its secretion by the fungus during invasion of the host lung. Infect Immun 1995; 63: 3796803.
  • 44
    Farley PC, Sullivan PA. The Rhizopus oryzae secreted aspartic proteinase gene family: an analysis of gene expression. Microbiology 1998; 8: 235566.
  • 45
    Paoletti M, Clave C, Begueret J. Characterization of a gene from the filamentous fungus Podospora anserine encoding an aspartyl protease induced upon carbon starvation. Gene 1998; 27: 4552.
  • 46
    Murakami K, Aikawa J, Horinouchi S, Beppu T. Characterization of an aspartic proteinase of Mucor pusillus expressed in Aspergillus oryzae. Mol Gen Genet 1993; 241: 3128.
  • 47
    Reichard U, Monod M, Odds F, Ruchel R. Virulence of an aspergillopepsin-deficient mutant of Aspergillus fumigatus and evidence for another aspartic proteinase linked to the fungal cell wall. J Med Vet Mycol 1997; 35: 18996.
  • 48
    Reichard U. The significance of secretory and structure-associated proteases of Aspergillus fumigatus for the pathogenesis of invasive aspergillosis. Mycoses 1998; 41(Suppl. 1): 7882.
  • 49
    Hasegawa Y, Nikai T, Ogawa K, Sugihara H. The effect of an Aspergillus fumigatus derived elastolytic proteinase on human neutrophils. Nippon Ishinkin Gakkai Zasshi 1999; 40: 2358.
  • 50
    Kothary MH, Chase T Jr, Macmillan JD. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun 1984; 43: 3205.
  • 51
    Blanco JL, Hontecillas R, Bouza E et al. Correlation between the elastase activity index and invasiveness of clinical isolates of Aspergillus fumigatus. J Clin Microbiol 2002; 40: 18113.
  • 52
    Denning DW, Ward PN, Fenelon LE, Benbow EW. Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis. Infect Immun 1992; 60: 51536.
  • 53
    Kolattukudy PE, Lee JD, Rogers LM et al. Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun 1993; 61: 235768.
  • 54
    Pinel C, Monod M, Ambriose-Thomas P, Grillot R. Western blot detection of IgG anti-Aspergillus fumigatus elastase in sera of patients with aspergillosis. J Med Vet Mycol 1994; 32: 2314.
  • 55
    Iadarola P, Lungarella G, Martorana PA et al. Lung injury and degradation of extracellular matrix components by Aspergillus fumigatus serine proteinase. Exp Lung Res 1998; 24: 23351.
  • 56
    Kunert J, Kopecek P. Multiple forms of the serine protease Alp of Aspergillus fumigatus. Mycoses 2000; 43: 33947.
  • 57
    Ikegami Y, Amitani R, Murayama T et al. Effects of alkaline protease or restrictocin deficient mutants of Aspergillus fumigatus on human polymorphonuclear leukocytes. Eur Respir J 1998; 12: 60711.
  • 58
    Chakrabarti SK, Matsumura N, Ranu RS. Purification and characterization of an extracellular alkaline serine protease from Aspergillus terreus (IJIRA 6.2). Curr Microbiol 2000; 40: 23944.
  • 59
    Rhodes JC, Amlung TW, Miller MS. Isolation and characterization of an elastinolytic proteinase from Aspergillus flavus. Infect Immun 1990; 58: 252934.
  • 60
    Rhodes JC, Amlung TW. The elastinolytic proteinase of Aspergillus flavus is not glycosylated. J Med Vet Mycol 1991; 29: 40711.
  • 61
    Ramesh MV, Sirakova TD, Kolattukudy PE. Cloning and characterization of the cDNAs and genes (mep20) encoding homologous metalloproteinases from Aspergillus flavus and A. fumigatus. Gene 1995; 165: 1215.
  • 62
    Mori T, Matsumura M, Yamada K et al. Systemic aspergillosis caused by an aflatoxin-producing strain of Aspergillus flavus. Med Mycol 1998; 36: 10712.
  • 63
    Jahn B, Koch A, Schmidt A et al. Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun 1997; 65: 51107.
  • 64
    Da Silva Bahia MC, Haido RM, Figueiredo MH et al. Humoral immune response in aspergillosis: an immunodominant glycoprotein of 35kDa from Aspergillus flavus. Curr Microbiol 2003; 47: 1638.
  • 65
    Moon EY, Rhee DK, Pyo S. In vitro suppressive effect of aflatoxin B1 on murine peritoneal macrophage functions. Toxicology 1999; 133: 1719.
  • 66
    Fenelon LE, Hamilton AJ, Figueroa JI et al. Production of specific monoclonal antibodies to Aspergillus species and their use in immunohistochemical identification of aspergillosis. J Clin Microbiol 1999; 37: 12213.
  • 67
    Raisuddin S, Singh KP, Zaidi SI, Ray PK. Immunostimulating effects of protein A in immunosuppressed aflatoxin-intoxicated rats. Int J Immunopharmacol 1994; 16: 97784.
  • 68
    Bis WA. Studies of immunological activity of Aspergillus flavus Link III. Presence of antibodies against fungal antigens in the sera of persons from selected groups. Med Dosw Mikrobiol 1990; 42: 15662.
  • 69
    Bis WA. Study of immunological activity of Aspergillus flavus Link II. Immunogenicity, antigenic properties and evaluation of cross reactions of Aspergillus flavus antibodies with Aspergillus fumigatus antigens. Med Dosw Mikrobiol 1990; 42: 14955.
  • 70
    Reddy RV, Sharma RP. Effects of aflatoxin B1 on murine lymphocytic functions. Toxicology 1989; 54: 3144.
  • 71
    Wray BB, Harmon CA, Rushing EJ, Cole RJ. Precipitins to an aflatoxin-producing strain of Aspergillus flavus in patients with malignancy. J Cancer Res Clin Oncol 1982; 103: 1815.
  • 72
    Dolezal M, Dolezal M, Malolepszy A, Szygula U. Level of antibodies to Aspergillus flavus in women and the incidence of various disorders of reproductive functions. Pol Tyg Lek 1977; 32: 18657.
  • 73
    Aleksandrowicz J, Adamek T, Laskownicka Z, Porebska A, Zemburowa K. Studies on precipitating antibodies for Aspergillus flavus antigens in patients with proliferative diseases. Mater Med Pol 1973; 5: 2324.
  • 74
    Adamek T, Aleksandrowicz J, Laskownicka Z, Porebska A, Zemburowa K. Searching for antibodies against Aspergillus flavus antigens in patients with systemic prolifrative diseases. Pol Tyg Lek 1971; 26: 14701.
  • 75
    Tilden Eb, Hatton Eh, Freeman S, Williamson Wm, Koenig Vl. Preparation and properties of the endotoxins of Aspergillus fumigatus and Aspergillus flavus. Mycopathologia 1961; 14: 32546.
  • 76
    International Agency for Research on Cancer (IARC). Some Naturally Occurring Substances. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 10. Lyon: International Agency for Research on Cancer, 1976, 353 pp.
  • 77
    International Agency for Research on Cancer. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines, and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 56. Lyon: International Agency for Research on Cancer, 1993, 571 pp.
  • 78
    International Agency for Research on Cancer. Overall Evaluation of Carcinogenicity. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Supplement 7. Lyon: International Agency for Research on Cancer, 1987, 440 pp.
  • 79
    International Agency for Research on Cancer. Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 82. Lyon: International Agency for Research on Cancer, 2002.
  • 80
    Stoloff L. Aflatoxin as a cause of primary liver-cell cancer in the United States: a probability study. Nutr Cancer 1983; 5: 16586. Review.
  • 81
    Zhang YJ, Chen Y, Ahsan H et al. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett 2005; 221: 13543.
  • 82
    Wojnowski L, Turner PC, Pedersen B et al. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. Pharmacogenetics 2004; 14: 691700.
  • 83
    Eaton DL, Gallagher EP. Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 1994; 34: 13572. Review.
  • 84
    Trottier Y, Waithe WI, Anderson A. Kinds of mutations induced by aflatoxin B1 in a shuttle vector replicating in human cells transiently expressing cytochrome P4501A2 cDNA. Mol Carcinog 1992; 6: 1407.
  • 85
    Zarba A, Wild CP, Hall AJ et al. Aflatoxin M1 in human breast milk from Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis 1992; 13: 8914.
  • 86
    Somogyi A, Beck H. Nurturing and breast-feeding: exposure to chemicals in breast milk. Environ Health Perspect 1993; 101(Suppl. 2): 4552.
  • 87
    Weaver VM, Buckley TJ, Groopman JD. Approaches to environmental exposure assessment in children. Environ Health Perspect 1998; 106(Suppl. 3): 82732.
  • 88
    Autrup JL, Schmidt J, Autrup H. Exposure to aflatoxin B1 in animal-feed production plant workers. Environ Health Perspect 1993; 99: 1957.
  • 89
    Gosh SK, Desai MR, Pandya GL, Venkaiah K. Airborne aflatoxin in the grain processing industries in India. Am Ind Hyg Assoc J 1997; 58: 5836.
  • 90
    Selim MI, Juchems AM, Popendrof W. Assessing air-borne aflatoxin B1 during on-farm grain handling activities. Am Ind Hyg Assoc J 1998; 59: 2526.
  • 91
    Brera C, Caputi R, Miraglia M et al. Exposure assessment to mycotoxins in workplaces. Aflatoxins and ochratoxin A occurrence in air-borne dusts and human sera. Microchem J 2002; 73: 16773.
  • 92
    Pegues CF, Daar ES, Murthy AR. The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital. Infect Control Hosp Epidemiol 2001; 22: 3704.
  • 93
    Kusne S, Torre-Cisneros J, Mañez R et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992; 166: 137983.
  • 94
    Narimatsu H, Morishita Y, Kohno A et al. Systemic infection of Aspergillus flavus in a patient with acute lymphoblastic leukemia. Rinsho Ketsueki 2003; 44: 102631.
  • 95
    Nenoff P, Kliem C, Mittag M, Horn LC, Niederwieser D, Haustein UF. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation. Eur J Dermatol 2002; 12: 9398.
  • 96
    Araujo R, Rodrigues AG. Variability of germinative potential among pathogenic species of Aspergillus. J Clin Microbiol 2004; 42: 43357.
  • 97
    Mori T, Matsumura M, Yamada K, et al. Systemic aspergillosis caused by an aflatoxin-producing strain of Aspergillus flavus. Med Mycol 1998; 36: 10712.
  • 98
    Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 68592.
  • 99
    Greenberger PA. Clinical aspects of allergic bronchopulmonary aspergillosis. Front Biosci 2003; 8: s11927.
  • 100
    Kauffman HF. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front Biosci 2003; 8: e1906.
  • 101
    Mishra SK, Staib F, Krumhaar D, Steffen J, Voigt R, Abel T. Aspergillus serum precipitins in patients of a lung clinic. Dtsch Med Wochenschr 1976; 101: 137781.
  • 102
    Moss RB. Allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol 2002; 23: 87104.
  • 103
    Banerjee B, Kurup VP. Molecular biology of Aspergillus allergens. Front Biosci 2003; 8: s12839.
  • 104
    Singh BP, Banerjee B, Kurup VP. Aspergillus antigens associated with allergic bronchopulmonary aspergillosis. Front Biosci 2003; 8: s1029.
  • 105
    Chiner E et al. A pulmonary mycotic sequestrum during invasive aspergillosis. Ann Med Int 1990; 7: 3046.
  • 106
    Gonawardena SA, Ranasinghe KP, Arseculeratne SN, Seimon CR, Ajello L. Survey of mycotic and bacterial keratitis in Sri Lanka. Mycopathologia 1994; 127: 7781.
  • 107
    Khairallah SH, Byrne KA, Tabbara KF. Fungal keratitis in Saudi Arabia. Doc Ophthalmol 1992; 79: 26976.
  • 108
    Wong TY, Fong KS, Tan DT. Clinical and microbial spectrum of fungal keratitis in Singapore: a 5-year retrospective study. Int Ophthalmol 1997; 21: 12730.
  • 109
    Demicco DD, Reichman RC, Violette EJ, Winn WC Jr. Disseminated aspergillosis presenting with endophthalmitis. A case report and a review of the literature. Cancer 1984; 53: 19952001.
  • 110
    Chin GN, Goodman NL. Aspergillus flavus keratitis. Ann Ophthalmol 1978; 10: 4158.
  • 111
    Lance SE, Friberg TR, Kowalski RP. Aspergillus flavus endophthalmitis and retinitis in an intravenous drug abuser. A therapeutic success. Ophthalmology 1988; 95: 9479.
  • 112
    Center for Disease Control. Aspergillus endophthalmitis in intravenous-drug users – Kentucky. MMWR Morb Mortal Wkly Rep 1990; 39: 4849.
  • 113
    From the Centers for Disease Control. Aspergillus endophthalmitis in intravenous-drug users – Kentucky. JAMA 1990; 263: 941.
  • 114
    Winchester K, Mathers WD, Sutphin JE. Diagnosis of Aspergillus keratitis in vivo with confocal microscopy. Cornea 1997; 16: 2731.
  • 115
    Kaplan DM, Briscoe D, Niv A, Gatot A, Leiberman A, Fliss DM. Detection of sinus-induced orbital mycosis with standardized orbital ultrasonography: a case report. Ear Nose Throat J 2001; 80: 5768, 80, 82, passim.
  • 116
    Manfredi R, Mazzoni A, Cavicchi O, Santini D, Chiodo F. Invasive mycotic and actinomycotic oropharyngeal and craniofacial infection in two patients with AIDS. Mycoses 1994; 37: 20915.
  • 117
    Dal Conte I, Riva G, Obert R et al. Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole. Mycoses 1996; 39: 3714.
  • 118
    Meyohas MC, Roux P, Poirot JL, Meynard JL, Frottier J. Aspergillosis in acquired immunodeficiency syndrome. Pathol Biol (Paris) 1994; 42: 64751.
  • 119
    Holding KJ, Dworkin MS, Wan PC et al. Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project. Clin Infect Dis 2000; 31: 12537.
  • 120
    Mylonakis E, Barlam TF, Flanigan T, Rich JD. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest 1998; 114: 25162.
  • 121
    Wallace JM, Lim R, Browdy BL et al. Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest 1998; 114: 1317.
  • 122
    Lortholary O, Meyohas MC, Dupont B et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med 1993; 95: 17787.
  • 123
    Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J Infect Dis 1993; 167: 90511.
  • 124
    Kemper CA, Hostetler JS, Follansbee SE et al. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis 1993; 17: 34452.
  • 125
    Wrzolek MA, Brudkowska J, Kozlowski PB et al. Opportunistic infections of the central nervous system in children with HIV infection: report of 9 autopsy cases and review of literature. Clin Neuropathol 1995; 14: 18796.
  • 126
    Estes SA, Hendricks AA, Merz WG, Prystowsky SD. Aspergillus infection of the central nervous system in patients with acquired immunodeficiency syndrome. Arch Neurol 1990; 47: 1814.
  • 127
    Pursell KJ, Telzak EE, Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis 1992; 14: 1418.
  • 128
    Afeltra J, Meis JF, Mouton JW, Verweij PE. Prevention of invasive aspergillosis in AIDS by sulfamethoxazole. AIDS 2001; 15: 10678.
  • 129
    Estes SA, Hendricks AA, Merz WG, Prystowsky SD. Primary cutaneous aspergillosis. J Am Acad Dermatol 1980; 3: 397400.
  • 130
    Böhler K, Metze D, Poitschek C, Jurecka W. Cutaneous aspergillosis. Clin Exp Dermatol 1990; 15: 44650.
  • 131
    Svirshchevskaya EV, Kurup VP. Immunotherapy of allergic bronchopulmonary aspergillosis: a clinical and experimental approach. Front Biosci 2003; 8: s92101.
  • 132
    Allo MD, Miller J, Townsend T, Tan C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 1987; 317: 11058.
  • 133
    Grossman ME, Fithian EC, Behrens C, Bissinger J, Fracaro M, Neu HC. Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol 1985; 12: 3138.
  • 134
    Del Giudice P, Moulonguet L, Ranchin B, Abraham B, Sellier P. Cutaneous Aspergillus invasion from sinusitis. Clin Infect Dis 1999; 29: 6901.
  • 135
    Khatri ML, Stefanato CM, Benghazeil M, Shafi M, Kubba A, Bhawan J. Cutaneous and paranasal aspergillosis in an immunocompetent patient. Int J Dermatol 2000; 39: 8536.
  • 136
    Lai CS, Lin SD, Chou CK, Lin HJ. Aspergillosis complicating the grafted skin and free muscle flap in a diabetic. Plast Reconstr Surg 1993; 92: 5326.
  • 137
    Anderson LL, Giandoni MB, Keller RA, Grabski WJ. Surgical wound healing complicated by Aspergillus infection in a nonimmunocompromised host. Dermatol Surg 1995; 21: 799801.
  • 138
    Krunic AL, Medenica M, Busbey S. Solitary embolic cutaneous aspergillosis in the immunocompromised patient with acute myelogenous leukemia – a propos another case caused by Aspergillus flavus. Int J Dermatol 2003; 42: 94650.
  • 139
    Watsky KL, Eisen RN, Bolognia JL. Unilateral cutaneous emboli of Aspergillus. Arch Dermatol 1990; 126: 12147.
  • 140
    Surya Prakash Rao G, Mann SB, Talwar P, Arora MM. Primary mycotic infection of paranasal sinuses. Mycopathologia 1984; 84: 7376.
  • 141
    Viollier AF, Peterson DE, De Jongh CA et al. Aspergillus sinusitis in cancer patients. Cancer 1986; 58: 36671.
  • 142
    Iwen PC, Rupp ME, Hinrichs SH. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997; 24: 117884.
  • 143
    Parikh SL, Venkatraman G, DelGaudio JM. Invasive fungal sinusitis: a 15-year review from a single institution. Am J Rhinol 2004; 18: 7581.
  • 144
    Klapper SR, Lee AG, Patrinely JR, Stewart M, Alford EL. Orbital involvement in allergic fungal sinusitis. Ophthalmology 1997; 104: 2094100.
  • 145
    Cimerman M, Gunde-Cimerman N, Zalar P, Perkovic T. Femur osteomyelitis due to a mixed fungal infection in a previously healthy man. J Clin Microbiol 1999; 37: 15325.
  • 146
    Tang TJ, Janssen HL, Van Der Vlies CH et al. Aspergillus osteomyelitis after liver transplantation: conservative or surgical treatment? Eur J Gastroenterol Hepatol 2000; 12: 1236.
  • 147
    Auletta JJ, John CC. Spinal epidural abscesses in children: a 15-year experience and review of the literature. Clin Infect Dis 2001; 32: 916.
  • 148
    Witzig RS, Greer DL, Hyslop NE Jr. Aspergillus flavus mycetoma and epidural abscess successfully treated with itraconazole. J Med Vet Mycol 1996; 34: 1337.
  • 149
    Faure BT, Biondi JX, Flanagan JP, Clarke R. Aspergillar osteomyelitis of the acetabulum. A case report and review of the literature. Orthop Rev 1990; 19: 5864.
  • 150
    Olle JE, Mildvan D. Aspergillus osteomyelitis of the sternum description of a case and review of the literature. Enferm Infecc Microbiol Clin 1990; 8: 9496.
  • 151
    De Vuyst D, Surmont I, Verhaegen J, Vanhaecke J. Tibial osteomyelitis due to Aspergillus flavus in a heart transplant patient. Infection 1992; 20: 4849.
  • 152
    Chi CY, Fung CP, Liu CY. Aspergillus flavus epidural abscess and osteomyelitis in a diabetic patient. J Microbiol Immunol Infect 2003; 36: 1458.
  • 153
    Cortet B, Richard R, Deprez X et al. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol 1994; 21: 128791.
  • 154
    Vandecasteele SJ, Boelaert JR, Verrelst P, Graulus E, Gordts BZ. Diagnosis and treatment of Aspergillus flavus sternal wound infections after cardiac surgery. Clin Infect Dis 2002; 35: 88790.
  • 155
    Tarrand JJ, Lichterfeld M, Warraich I et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003; 119: 8548.
  • 156
    Haseman MK, Blake K, McDougall IR. Indium 111 WBC scan in local and systemic fungal infections. Arch Intern Med 1984; 144: 14623.
  • 157
    Verweij PE, Smedts F, Poot T et al. Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections. J Clin Pathol 1996; 49: 798801.
  • 158
    Chumpitazi BF, Pinel C, Lebeau B, Ambroise-Thomas P, Grillot R. Aspergillus fumigatus antigen detection in sera from patients at risk for invasive aspergillosis. J Clin Microbiol 2000; 38: 43843.
  • 159
    Kaufman L, Standard PG, Jalbert M, Kraft DE. Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies. J Clin Microbiol 1997; 35: 22069.
  • 160
    Woo PC, Chan CM, Leung AS et al. Detection of cell wall galactomannoprotein Afmp1p in culture supernatants of Aspergillus fumigatus and in sera of aspergillosis patients. J Clin Microbiol 2002; 40: 43827.
  • 161
    Chambon-Pautas C, Costa JM, Chaumette MT, Cordonnier C, Bretagne S. Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia. J Infect 2001; 43: 2134.
  • 162
    Costa C, Costa JM, Desterke C, Botterel F, Cordonnier C, Bretagne S. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2002; 40: 22247.
  • 163
    Pereira CN, Del Nero G, Lacaz CS, Machado CM. The contribution of galactomannan detection in the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Mycopathologia 2005; 159: 48793.
  • 164
    Pazos C, Ponton J, Del PalacioA. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005; 43: 299305.
  • 165
    Henry T, Iwen PC, Hinrichs SH. Identification of Aspergillus species using internal transcribed spacer regions 1 and 2. J Clin Microbiol 2000; 38: 15105.
  • 166
    Park CS, Kim J, Montone KT. Detection of Aspergillus ribosomal RNA using biotinylated oligonucleotides probes. Dign Mol Pathol 1997; 6: 25560.
  • 167
    Hendolin PH, Paulin L, Koukila-Kahkola P et al. Panfungal PCR and multiplex liquid hybridization for detection of fungi in tissue specimens. J Clin Microbiol 2000; 38: 418692.
  • 168
    De AguirreL, Hurst SF, Choi JS et al. Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol 2004; 42: 3495504.
  • 169
    Martin C, Roberts D, Van DerWeideM et al. Development of a PCR-based line probe assay for identification of fungal pathogens. J Clin Microbiol 2000; 38: 373542.
  • 170
    James MJ, Lasker BA, McNeil MM et al. Use of repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in neonatal intensive care unit. J Clin Microbiol 2000; 38: 36128.
  • 171
    Bu R, Sathiapalan RK, Ibrahim MM et al. Monochrome LightCycler PCR assay for detection and quantification of five common species of Candida and Aspergillus. J Med Microbiol 2005; 54: 2438.
  • 172
    De Aguirre L, Hurst SF, Choi JS, Shin JH, Hinrikson HP, Morrison CJ. Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol 2004; 42: 3495504.
  • 173
    Sugita C, Makimura K, Uchida K, Yamaguchi H, Nagai A. PCR identification system for the genus Aspergillus and three major pathogenic species: Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger. Med Mycol 2004; 42: 4337.
  • 174
    Johnson EM, Szekely A, Warnock DW. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998; 42: 7415.
  • 175
    Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989; 2: 791800.
  • 176
    Koss T, Bagheri B, Zeana C, Romagnoli MF, Grossman ME. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent. J Am Acad Dermatol 2002; 46: 9457.
  • 177
    Paterson PJ, Seaton S, Prentice HG, Kibbler CC. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. J Antimicrob Chemother 2003; 52: 8736.
  • 178
    Cacciapuoti A, Loebenberg D, Corcoran E et al. In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother 2000; 44: 201722.
  • 179
    Munayyer HK, Mann PA, Chau AS et al. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds. Antimicrob Agents Chemother 2004; 48: 36906.
  • 180
    Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Update 2005; 8: 34458.
  • 181
    Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal drug resistance in Aspergillus. J Infect 2000; 41: 20320.
  • 182
    Varanasi NL, Manavathu EK, Baskaran I, Alangaden GJ, Thomas PA, Chandrasekar PH. In Vitro Susceptibility and Azole Resistance Among Clinical and Laboratory-Selected Isolates of Aspergillus Flavus Obtained From Three Continents. Chicago, IL: Abstracts of the 41st ICAAC, 2001. December 16–19, 2001, Abstract J-271.
  • 183
    Hsueh PR, Lau YJ, Chuang YC et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 2005; 49: 5127.
  • 184
    Peterson PJ, Seaton S, Prentice HG, Kibbler CC. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. J Antimicrob Chemother 2003; 52: 8736.
  • 185
    Koss T, Bagheri B, Zeana C, Romagnoli MF, Grossman ME. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent. J Am Acad Dermatol 2002; 46: 9457.
  • 186
    Abraham OC, Manavathu EK, Cutright JL, Chandrasekar PH. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole and amphotericin B. Diagn Microbiol Infect Dis 1998; 33: 711.
  • 187
    Manavathu EK, Cutright JL, Loebenberg D, Chandrasekar PH. A comparative study of the in vitro susceptibilities of clinical, and laboratory-selected resistant isolates of Aspergillus species to amphotericin B, itraconazole, voriconazole and posaconazole (SCH56592). 2000. J Antimicrob Chemother 2000; 46: 22934.
  • 188
    Seo K, Akiyoshi H, Ohnishi Y. Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus. Microbiol Immunol 1999; 43: 101725.
  • 189
    Rose HD, Hirsch SR. Filtering hospital air decreases Aspergillus spore counts. Am Rev Respir Dis 1979; 119: 5113.
  • 190
    Sarubbi FA Jr, Kopf HB, Wilson MB, McGinnis MR, Rutala WA. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 1982; 125: 3338.
  • 191
    Hahn T, Cummings KM, Michalek AM, Lipman BJ, Segal BH, McCarthy PL Jr. Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol 2002; 23: 52531.
  • 192
    Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak setting. J Hosp Infect 2006; 63: 24654.
  • 193
    Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Gaztelurrutia L, Navarro JI, Tudela JL. Genetic similarity among one Aspergillus flavus strain isolated from a patient who underwent heart surgery and two environmental strains obtained from the operating room. J Clin Microbiol 2000; 38: 241922.
  • 194
    James MJ, Lasker BA, McNeil MM, Shelton M, Warnock DW, Reiss E. Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit. J Clin Microbiol 2000; 38: 36128.
  • 195
    Leenders A, Van Belkum A, Janssen S et al. Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward. J Clin Microbiol 1996; 34: 34551.
  • 196
    Price DL, Simmons RB, Crow SA Jr, Ahearn DG. Mold colonization during use of preservative-treated and untreated air filters, including HEPA filters from hospitals and commercial locations over an 8-year period (1996–2003). J Ind Microbiol Biotechnol 2005; 32: 31921.
  • 197
    Khan ZU, Gopalakrishnan G, Al-Awadi K et al. Renal aspergilloma due to Aspergillus flavus. Clin Infect Dis 1995; 21: 2102.
  • 198
    Casey AT, Wilkins P, Uttley D. Aspergillosis infection in neurosurgical practice. Br J Neurosurg 1994; 8: 3139.
  • 199
    Torre-Cisneros J, Lopez OL, Kusne S et al. CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Nerosurg Psychiatry 1993; 56: 18893.
  • 200
    Pérez-Arellano JL, Angel-Moreno A, Belón E, Francès A, Santana OE, Martín-Sánchez AM. Isolated renoureteric aspergilloma due to Aspergillus flavus: case report and review of the literature. J Infect 2001; 42: 1635.
  • 201
    Chu CM, Woo PC, Chong KT, Leung WS, Chan VL, Yuen KY. Association of presence of Aspergillus antibodies with hemoptysis in patients with old tuberculosis or bronchiectasis but no radiographically visible mycetoma. J Clin Microbiol 2004; 42: 6659.
  • 202
    Matsumura M, Mori T. Detection of aflatoxins in autopsied materials from a patient infected with Aspergillus flavus. Nippon Ishinkin Gakkai Zasshi 1998; 39: 16771.
  • 203
    Verghese S, Maria CF, Mullaseri AS, Asha M, Padmaja P, Padhye AA. Aspergillus endicarditis presenting as femoral artery embolism. Mycoses, 2004; 47: 2526.
  • 204
    Wilson AP, Wright S, Bellingan G. Disseminated fungal infection following falciparum malaria. J Infect 2000; 40: 2024.
  • 205
    Demaria RG, Dürrleman N, Rispail P et al. Aspergillus flavus mitral valve endocarditis after lung abscess. J Heart Valve Dis 2000; 9: 78690.
  • 206
    Wong J, McCracken G, Ronan S, Aronson I. Coexistent cutaneous Aspergillus and cytomegalovirus infection in a liver transplant recipient. J Am Acad Dermatol 2001; 2(Suppl.): 3702.
  • 207
    Wandschneider W, Deutsch M. Fatal fungal infection of an ascending aortic graft. Thorac Cardiovasc Surg 1995; 43: 2179.
  • 208
    Harley WB, Dummer JS, Anderson TL, Goodman S. Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs. Clin Infect Dis 1995; 20: 10524.
  • 209
    Drakos PE, Nagler A, Or R et al. Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993; 12: 2038.
  • 210
    Shitara T, Yugami S-I, Sotomatu M et al. Invasive aspergillosis in leukemic children. Pediatr Hematol Oncol 1993; 10: 16974.
  • 211
    Harmon CB, Daniel WP, Peters MS. Cutaneous aspergillosis complicating pyoderma gangrenosum. J Am Acad Dermatol 1993; 29: 6568.
  • 212
    Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002; 292: 10713.
  • 213
    Youngchim S, Morris-Jones R, Hay RJ, Hamilton AJ. Production of melanin by Aspergillus fumigatus. J Med Microbiol 2004; 53: 17581.
  • 214
    Langfelder K, Streibel M, Jahn B, Haase G, Brakhage AA. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet Biol 2003; 38: 14358.